ロード中...
Molecular profiling of tumours for precision oncology – high hopes versus reality
Treatment based on molecular profiling of tumor is advertised however there are very limited clinical data supporting this approach so far. Only one, relatively small, randomized clinical trial (SHIVA) have not met its primary endpoint - prolongation of PFS. Some other unpublished series were report...
保存先:
| 出版年: | Contemp Oncol (Pozn) |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Termedia Publishing House
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5885080/ https://ncbi.nlm.nih.gov/pubmed/29628787 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2018.73873 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|